Cargando…

Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands

The occurrence of epithelial-mesenchymal transition (EMT) within tumors, which enables invasion and metastasis, is linked to cancer stem cells (CSCs) with drug and radiation resistance. We used two specific peptides, F7 and SP peptides, to detect EMT derived cells or CSCs. Human tongue squamous carc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-An, Ho, Cheau-Ling, Ku, Min-Tzu, Hwu, Luen, Lu, Cheng-Hsiu, Chiu, Sain-Jhih, Chang, Wen-Yi, Liu, Ren-Shyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599855/
https://www.ncbi.nlm.nih.gov/pubmed/34789743
http://dx.doi.org/10.1038/s41598-021-01138-0
_version_ 1784601032525873152
author Chen, Yi-An
Ho, Cheau-Ling
Ku, Min-Tzu
Hwu, Luen
Lu, Cheng-Hsiu
Chiu, Sain-Jhih
Chang, Wen-Yi
Liu, Ren-Shyan
author_facet Chen, Yi-An
Ho, Cheau-Ling
Ku, Min-Tzu
Hwu, Luen
Lu, Cheng-Hsiu
Chiu, Sain-Jhih
Chang, Wen-Yi
Liu, Ren-Shyan
author_sort Chen, Yi-An
collection PubMed
description The occurrence of epithelial-mesenchymal transition (EMT) within tumors, which enables invasion and metastasis, is linked to cancer stem cells (CSCs) with drug and radiation resistance. We used two specific peptides, F7 and SP peptides, to detect EMT derived cells or CSCs. Human tongue squamous carcinoma cell line-SAS transfected with reporter genes was generated and followed by spheroid culture. A small molecule inhibitor-Unc0642 and low-dose ionizing radiation (IR) were used for induction of EMT. Confocal microscopic imaging and fluorescence-activated cell sorting analysis were performed to evaluate the binding ability and specificity of peptides. A SAS xenograft mouse model with EMT induction was established for assessing the binding affinity of peptides. The results showed that F7 and SP peptides not only specifically penetrated into cytoplasm of SAS cells but also bound to EMT derived cells and CSCs with high nucleolin and vimentin expression. In addition, the expression of CSC marker and the binding of peptides were increased in tumors isolated from Unc0642/IR-treated groups. Our study demonstrates the potential of these peptides for detecting EMT derived cells or CSCs and might provide an alternative isolation method for these subpopulations within the tumor in the future.
format Online
Article
Text
id pubmed-8599855
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85998552021-11-19 Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands Chen, Yi-An Ho, Cheau-Ling Ku, Min-Tzu Hwu, Luen Lu, Cheng-Hsiu Chiu, Sain-Jhih Chang, Wen-Yi Liu, Ren-Shyan Sci Rep Article The occurrence of epithelial-mesenchymal transition (EMT) within tumors, which enables invasion and metastasis, is linked to cancer stem cells (CSCs) with drug and radiation resistance. We used two specific peptides, F7 and SP peptides, to detect EMT derived cells or CSCs. Human tongue squamous carcinoma cell line-SAS transfected with reporter genes was generated and followed by spheroid culture. A small molecule inhibitor-Unc0642 and low-dose ionizing radiation (IR) were used for induction of EMT. Confocal microscopic imaging and fluorescence-activated cell sorting analysis were performed to evaluate the binding ability and specificity of peptides. A SAS xenograft mouse model with EMT induction was established for assessing the binding affinity of peptides. The results showed that F7 and SP peptides not only specifically penetrated into cytoplasm of SAS cells but also bound to EMT derived cells and CSCs with high nucleolin and vimentin expression. In addition, the expression of CSC marker and the binding of peptides were increased in tumors isolated from Unc0642/IR-treated groups. Our study demonstrates the potential of these peptides for detecting EMT derived cells or CSCs and might provide an alternative isolation method for these subpopulations within the tumor in the future. Nature Publishing Group UK 2021-11-17 /pmc/articles/PMC8599855/ /pubmed/34789743 http://dx.doi.org/10.1038/s41598-021-01138-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Chen, Yi-An
Ho, Cheau-Ling
Ku, Min-Tzu
Hwu, Luen
Lu, Cheng-Hsiu
Chiu, Sain-Jhih
Chang, Wen-Yi
Liu, Ren-Shyan
Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands
title Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands
title_full Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands
title_fullStr Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands
title_full_unstemmed Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands
title_short Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands
title_sort detection of cancer stem cells by emt-specific biomarker-based peptide ligands
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599855/
https://www.ncbi.nlm.nih.gov/pubmed/34789743
http://dx.doi.org/10.1038/s41598-021-01138-0
work_keys_str_mv AT chenyian detectionofcancerstemcellsbyemtspecificbiomarkerbasedpeptideligands
AT hocheauling detectionofcancerstemcellsbyemtspecificbiomarkerbasedpeptideligands
AT kumintzu detectionofcancerstemcellsbyemtspecificbiomarkerbasedpeptideligands
AT hwuluen detectionofcancerstemcellsbyemtspecificbiomarkerbasedpeptideligands
AT luchenghsiu detectionofcancerstemcellsbyemtspecificbiomarkerbasedpeptideligands
AT chiusainjhih detectionofcancerstemcellsbyemtspecificbiomarkerbasedpeptideligands
AT changwenyi detectionofcancerstemcellsbyemtspecificbiomarkerbasedpeptideligands
AT liurenshyan detectionofcancerstemcellsbyemtspecificbiomarkerbasedpeptideligands